OXYGENATE THE WORLD

Our mission

NOVAIR is working for a world that breathes better by reinventing access to the air gases essential to human life and activity, for everyone, everywhere, and in a sustainable way.

No more incessant deliveries of liquid  or bottled gas by trucks polluting our atmosphere.
No more storing and handling gas cylinders, with all the safety risks that entails.
No more exposure to the risks of supply in a world with an increasingly unstable climate.
No more depending on the major gas producers who have dominated the market for decades.

NOVAIR liberates and enables every hospital and every industry, whether in densely populated or isolated areas, to manage its medical oxygen or nitrogen supply autonomously.

Our generators go for extreme purity and can offer oxygen purity of up to 99.5%, a world first today.
Our generators have optimized energy consumption to meet both economic and ecological challenges.
Our generators guarantee continuous operation, thanks to autonomous production and guaranteed after-sales service at any time, anywhere in the world.

At NOVAIR, we innovate every day to ensure that everyone, everywhere in the world, has access to the best air while preserving it.

Our Values

N

NOVAIR today

NOVAIR is headquartered in France and has several subsidiaries in Europe - Italy, Germany - and the United States.

Three plants and R&D centers spread over 17,500 m2 design, manufacture, and ship NOVAIR solutions worldwide.

The company employs over 200 people worldwide and operates in more than 150 countries via affiliated and trained distributors and partners.

NOVAIR service teams also provide a direct local and regional presence in many countries in Africa, Asia, and South America.

47
Years in business
4500
Autonomous customers
150
Countries covered
3
Plants and R&D centers

Our History

An independent, family-owned company, NOVAIR was founded in 1977 by Bernard ZENOU, in the Paris region.

Behind the technology offered by the company lies a singular human story, that of an entrepreneur at heart, who started this adventure in a garage, alongside his wife Maguy ZENOU, in charge of administration. With a degree in mechanical engineering, he began his career with a company specializing in compressed air, and quickly decided to move into this field, where he had already gained his first experience; NOVAIR was born.

Initially supplying compressors and vacuum pumps to users in healthcare and industry, the company gradually turned to larger-scale projects. In the early 90s, NOVAIR designed its first medical air and vacuum systems, then diversified into medical oxygen, making it a specialty.

An active member of ISO and AFNOR, NOVAIR participates in the drafting committees of most European and international standards concerning the production and distribution of oxygen and medical fluids. Today, the medical oxygen generator has a regulatory framework for which Bernard Zenou, NOVAIR's founding president, fought for many years.

NOVAIR and COVID19

It was the COVID epidemic that revealed to the world the essential contribution of Novair stand-alone generators. The need for medical oxygen multiplied, in the four corners of the world and even in the most isolated places. Novair emerged as an essential resource, and became the preferred partner of WHO, UNOPS and UNDP, as well as NGOs such as MSF, UNICEF, and Partners In Health.

Oxygenate the world

Today, thousands of hospitals on every continent are equipped to make medical oxygen accessible to all, at all times. Novair not only helps people breathe easier but also our planet, since its approach avoids the carbon emissions associated with transporting gas cylinders by road. More oxygen, less carbon: that's our program.

Novair also embodies a more humane social model. With some 100 employees in France and more than 200 abroad, it favors a model that promotes the equitable sharing of wealth and genuine attention to well-being within the company.

An ambition and a battle

In 1995, Bernard ZENOU adapted a technology originally intended for oxygen concentrators for home treatment of patients suffering from respiratory insufficiency, using a molecular sieve to separate oxygen and nitrogen. A forerunner, he saw the potential, worked on improving the technology, and decided to deploy it on a larger scale, within the hospital. NOVAIR became the first player in Europe to offer systems for the highly innovative on-site production of medical oxygen. Despite its obvious potential, the generator aroused skepticism and reluctance. The creator embarked on a bitter battle to impose this technology, in which he firmly believed, but had to contend with competition from highly influential multinationals.

An active member of ISO and AFNOR, NOVAIR participates in the drafting committees of most European and international standards concerning the production and distribution of oxygen and medical fluids. Today, the medical oxygen generator has a regulatory framework for which Bernard Zenou, NOVAIR's founding president, fought for many years.

NOVAIR and COVID19

It was the COVID epidemic that revealed to the world the essential contribution of Novair stand-alone generators. The need for medical oxygen multiplied, in the four corners of the world and even in the most isolated places. Novair emerged as an essential resource, and became the preferred partner of WHO, UNOPS and UNDP, as well as NGOs such as MSF, UNICEF, and Partners In Health.

Oxygenate the World

Today, thousands of hospitals on every continent are equipped to make medical oxygen accessible to all, at all times. Novair not only helps people breathe easier but also our planet, since its approach avoids the carbon emissions associated with transporting gas cylinders by road. More oxygen, less carbon: that's our program.

Novair also embodies a more humane social model. With some 100 employees in France and more than 200 abroad, it favors a model that promotes the equitable sharing of wealth and genuine attention to well-being within the company.

Awards

Technologies for every need

With over 45 years of experience, NOVAIR has developed in-depth knowledge of all air separation technologies for on-site nitrogen or oxygen production and offers the widest choice of generators on the market. Depending on the flow rate and purity required, NOVAIR offers the most appropriate technology:

 

 

PSA

PSA

PSA technology

PSA (Pressure Swing Adsorption) technology separates gases from air using a molecular sieve capable of adsorbing nitrogen/oxygen under pressure.

DS-PSA

DS-PSA

The two-stage PSA

An exclusive NOVAIR know-how, DS-PSA (Double-Stage PSA) is based on a two-stage PSA molecular separation process.

R-PSA

R-PSA

The rotative PSA

The latest NOVAIR technology, the R-PSA is based on an innovative rotary PSA process implemented in a minimum of space.

M-PSA

M-PSA

The modular PSA

Modular PSA generators are composed of multiple molecular sieve modules for optimum flexibility.

L-PSA

L-PSA

High-efficiency PSA

The combination of PSA and low pressure for maximum energy efficiency.

V-PSA

V-PSA

V-PSA

NOVAIR's Vacuum PSA is designed for sites and facilities requiring the highest oxygen production capacities.